ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
1
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
233
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
289: Cadonilimab, an anti-PD1/CTLA4 bi-specific antibody with Fc effector null backbone
Author(s):
Z. Huang
,
X. PANG
,
T. Zhong
,
N. CHEN
,
X HE
,
D Xia
Publication date:
2021
Journal:
J Immunother Cancer
Read this article at
ScienceOpen
Further versions
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Anti-Trafficking Review
Data availability:
Comments
Comment on this article
Sign in to comment
Related Documents Log
Similar content
233
Efficacy and safety of cadonilimab, an anti-PD-1/CTLA4 Bi-specifc antibody, in previously treated recurrent or metastatic (R/M) cervical cancer: a multicenter, open-label, single-arm, phase II trial
Authors:
X Wu
,
J JI
,
H Lou
Abstract 2270: RG7769 (PD1-TIM3), a novel heterodimeric avidity-driven T cell specific PD-1/TIM-3 bispecific antibody lacking Fc-mediated effector functions for dual checkpoint inhibition to reactivate dysfunctional T cells
Authors:
Laura Deak
,
Stefan Seeber
,
Mario Perro
…
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart
Authors:
Amir Z. Munir
,
Alan Gutierrez
,
Juan Qin
…
See all similar
Cited by
1
Application and future prospects of bispecific antibodies in the treatment of non-small cell lung cancer
Authors:
Junxu Wen
,
Wenxing Cui
,
Xiaoyan Yin
…
See all cited by